close
close

KFSHRC is committed to pioneering work in the field of treatment with medical therapies and serious health problems

KFSHRC is committed to pioneering work in the field of treatment with medical therapies and serious health problems

RIAD, Saudi Arabia, Oct. 20, 2024 (GLOBE NEWSWIRE) — The King Faisal Specialist Hospital Research Center (KFSHRC) has revolutionized credit treatment in the region with transformative therapy with CAR-T-Zell therapy and CRISPR medicine . With a period of 40 years, the KFSHRC can obtain a well-considered delivery offer from bahnbrechender personalizable credit treatment.

In January 2023, the oncology exzellenzz center treated 25% of the Krebsfälle in Saudi Arabia and achieved a health rate of 50% and a recovery health rate of 90% in leukemia patients.

As one of the healthy people, if the CAR-T-Zell Therapy is offered, the KFSHRC can undergo the broke treatment during the program development of patients’ immunity. Since 2021, more than 100 patients have been discussed, the first fall of 13 years, nice patients. In the year 2023, 59 CAR-T-Zell therapies had been completed, an outcome of 62% was successful, and the fun-life-over-life rate in pediatric kidney tumors was 97%. The KFSHRC has pioneered local production of CAR-T-Zellen, a way to save and reduce costs.

With the pediatric onkology program of the KFSHRC, which has appeared at the King Fahd National Center for Children’s Cancer (KFNCCC), there is a Strahl of the Hoffnung: 92% of the fall of the lymphoblastic leukemia (ALL) was revealed. There are more than 3,000 patients with stem cell transplants who have been treated by the KFSHRC in the local Umfeld ermöglicht, while the patients are no longer developed in the Ausland.

The KFSHRC is working on the genomic media with CRISPR-Cas9 generation and personalization of credit therapies, allowing the use of technically very advanced machines in healthcare for the accelerated selection of diseases. Gene therapy studies for hamphilia and PNH have made significant contributions and costs.

The KFSHRC has played a role in immunology and genome therapy with the completion of a number of studies, in the midpoint patient, therapeutic treatment offered and general wellness care provided.

It is a brand that the KFSHRC has held in first place in the Nahen East and Africa and 20th over the years. Platz weltweit on the list of the 250 best academic media outlets in the world that have been awarded the Brand Finance Ranking 2024 as the most valued Marke. In the general interest of the royal family and the Nahen East, the war continues. Darüber would appear in the course of time of the Zeitschrift Newsweek in the list of the 250 best Krankenhäuser der Welt and in the list of World’s Best Smart Hospitals for the launch of 2025. For more information, see www.kfshrc.edu.sa or our media team (email protected)

Resources contact:
Essam AlZahrani
966 55 525 4429
(email protected)

A photo of the latter can be found at https://www.globenewswire.com/NewsRoom/AttachmentNg/4be2976d-d0b1-4ac1-a07c-4fb5015c611a

Quelle Hugin